Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and ...

Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.

In a warning letter, the Food and Drug Administration said Glenmark Pharmaceuticals failed to properly investigate flaws with a generic drug that ProPublica found was linked to U.S. deaths.

Speakers at a congressional briefing on July 22 called on the FDA to take action against the marketing and distribution of ...

Alert FDA OKs Skytrofa for Growth Hormone Deficiency in Adults The once-weekly injection, already approved in pediatric patients with GHD, offers convenience over daily injections.